May 09, 2019
American Health Packaging is recalling a single lot of glipizide extended-release tablets, 2.5 mg, 30-tablet blister packs (NDC 68084-295-21) because samples from the repackaged lot failed to meet dissolution specifications during routine testing, according to the May 8, 2019, US Food and Drug Administration (FDA) Enforcement Report.
The recall affects tablets from lot 181288 (Exp. 5/31/20). The medication was distributed throughout the United States.
American Health Packaging voluntarily issued the recall April 8, 2019. At press time, the FDA had not yet classified the recall.
Extended-release glipizide is a prescription medication used to control blood sugar levels in people with type 2 diabetes.